Cargando…

18F-Fluorodeoxyglucose Positron Emission Tomography of Head and Neck Cancer: Location and HPV Specific Parameters for Potential Treatment Individualization

PURPOSE: 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) is utilized for staging and treatment planning of head and neck squamous cell carcinomas (HNSCC). Some older publications on the prognostic relevance showed inconclusive results, most probably due to small study sizes. This study...

Descripción completa

Detalles Bibliográficos
Autores principales: Zschaeck, Sebastian, Weingärtner, Julian, Lombardo, Elia, Marschner, Sebastian, Hajiyianni, Marina, Beck, Marcus, Zips, Daniel, Li, Yimin, Lin, Qin, Amthauer, Holger, Troost, Esther G. C., van den Hoff, Jörg, Budach, Volker, Kotzerke, Jörg, Ferentinos, Konstantinos, Karagiannis, Efstratios, Kaul, David, Gregoire, Vincent, Holzgreve, Adrien, Albert, Nathalie L., Nikulin, Pavel, Bachmann, Michael, Kopka, Klaus, Krause, Mechthild, Baumann, Michael, Kazmierska, Joanna, Cegla, Paulina, Cholewinski, Witold, Strouthos, Iosif, Zöphel, Klaus, Majchrzak, Ewa, Landry, Guillaume, Belka, Claus, Stromberger, Carmen, Hofheinz, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213669/
https://www.ncbi.nlm.nih.gov/pubmed/35756665
http://dx.doi.org/10.3389/fonc.2022.870319
_version_ 1784730886040715264
author Zschaeck, Sebastian
Weingärtner, Julian
Lombardo, Elia
Marschner, Sebastian
Hajiyianni, Marina
Beck, Marcus
Zips, Daniel
Li, Yimin
Lin, Qin
Amthauer, Holger
Troost, Esther G. C.
van den Hoff, Jörg
Budach, Volker
Kotzerke, Jörg
Ferentinos, Konstantinos
Karagiannis, Efstratios
Kaul, David
Gregoire, Vincent
Holzgreve, Adrien
Albert, Nathalie L.
Nikulin, Pavel
Bachmann, Michael
Kopka, Klaus
Krause, Mechthild
Baumann, Michael
Kazmierska, Joanna
Cegla, Paulina
Cholewinski, Witold
Strouthos, Iosif
Zöphel, Klaus
Majchrzak, Ewa
Landry, Guillaume
Belka, Claus
Stromberger, Carmen
Hofheinz, Frank
author_facet Zschaeck, Sebastian
Weingärtner, Julian
Lombardo, Elia
Marschner, Sebastian
Hajiyianni, Marina
Beck, Marcus
Zips, Daniel
Li, Yimin
Lin, Qin
Amthauer, Holger
Troost, Esther G. C.
van den Hoff, Jörg
Budach, Volker
Kotzerke, Jörg
Ferentinos, Konstantinos
Karagiannis, Efstratios
Kaul, David
Gregoire, Vincent
Holzgreve, Adrien
Albert, Nathalie L.
Nikulin, Pavel
Bachmann, Michael
Kopka, Klaus
Krause, Mechthild
Baumann, Michael
Kazmierska, Joanna
Cegla, Paulina
Cholewinski, Witold
Strouthos, Iosif
Zöphel, Klaus
Majchrzak, Ewa
Landry, Guillaume
Belka, Claus
Stromberger, Carmen
Hofheinz, Frank
author_sort Zschaeck, Sebastian
collection PubMed
description PURPOSE: 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) is utilized for staging and treatment planning of head and neck squamous cell carcinomas (HNSCC). Some older publications on the prognostic relevance showed inconclusive results, most probably due to small study sizes. This study evaluates the prognostic and potentially predictive value of FDG-PET in a large multi-center analysis. METHODS: Original analysis of individual FDG-PET and patient data from 16 international centers (8 institutional datasets, 8 public repositories) with 1104 patients. All patients received curative intent radiotherapy/chemoradiation (CRT) and pre-treatment FDG-PET imaging. Primary tumors were semi-automatically delineated for calculation of SUV(max), SUV(mean), metabolic tumor volume (MTV) and total lesion glycolysis (TLG). Cox regression analyses were performed for event-free survival (EFS), overall survival (OS), loco-regional control (LRC) and freedom from distant metastases (FFDM). RESULTS: FDG-PET parameters were associated with patient outcome in the whole cohort regarding clinical endpoints (EFS, OS, LRC, FFDM), in uni- and multivariate Cox regression analyses. Several previously published cut-off values were successfully validated. Subgroup analyses identified tumor- and human papillomavirus (HPV) specific parameters. In HPV positive oropharynx cancer (OPC) SUV(max) was well suited to identify patients with excellent LRC for organ preservation. Patients with SUV(max) of 14 or less were unlikely to develop loco-regional recurrence after definitive CRT. In contrast FDG PET parameters deliver only limited prognostic information in laryngeal cancer. CONCLUSION: FDG-PET parameters bear considerable prognostic value in HNSCC and potential predictive value in subgroups of patients, especially regarding treatment de-intensification and organ-preservation. The potential predictive value needs further validation in appropriate control groups. Further research on advanced imaging approaches including radiomics or artificial intelligence methods should implement the identified cut-off values as benchmark routine imaging parameters.
format Online
Article
Text
id pubmed-9213669
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92136692022-06-23 18F-Fluorodeoxyglucose Positron Emission Tomography of Head and Neck Cancer: Location and HPV Specific Parameters for Potential Treatment Individualization Zschaeck, Sebastian Weingärtner, Julian Lombardo, Elia Marschner, Sebastian Hajiyianni, Marina Beck, Marcus Zips, Daniel Li, Yimin Lin, Qin Amthauer, Holger Troost, Esther G. C. van den Hoff, Jörg Budach, Volker Kotzerke, Jörg Ferentinos, Konstantinos Karagiannis, Efstratios Kaul, David Gregoire, Vincent Holzgreve, Adrien Albert, Nathalie L. Nikulin, Pavel Bachmann, Michael Kopka, Klaus Krause, Mechthild Baumann, Michael Kazmierska, Joanna Cegla, Paulina Cholewinski, Witold Strouthos, Iosif Zöphel, Klaus Majchrzak, Ewa Landry, Guillaume Belka, Claus Stromberger, Carmen Hofheinz, Frank Front Oncol Oncology PURPOSE: 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) is utilized for staging and treatment planning of head and neck squamous cell carcinomas (HNSCC). Some older publications on the prognostic relevance showed inconclusive results, most probably due to small study sizes. This study evaluates the prognostic and potentially predictive value of FDG-PET in a large multi-center analysis. METHODS: Original analysis of individual FDG-PET and patient data from 16 international centers (8 institutional datasets, 8 public repositories) with 1104 patients. All patients received curative intent radiotherapy/chemoradiation (CRT) and pre-treatment FDG-PET imaging. Primary tumors were semi-automatically delineated for calculation of SUV(max), SUV(mean), metabolic tumor volume (MTV) and total lesion glycolysis (TLG). Cox regression analyses were performed for event-free survival (EFS), overall survival (OS), loco-regional control (LRC) and freedom from distant metastases (FFDM). RESULTS: FDG-PET parameters were associated with patient outcome in the whole cohort regarding clinical endpoints (EFS, OS, LRC, FFDM), in uni- and multivariate Cox regression analyses. Several previously published cut-off values were successfully validated. Subgroup analyses identified tumor- and human papillomavirus (HPV) specific parameters. In HPV positive oropharynx cancer (OPC) SUV(max) was well suited to identify patients with excellent LRC for organ preservation. Patients with SUV(max) of 14 or less were unlikely to develop loco-regional recurrence after definitive CRT. In contrast FDG PET parameters deliver only limited prognostic information in laryngeal cancer. CONCLUSION: FDG-PET parameters bear considerable prognostic value in HNSCC and potential predictive value in subgroups of patients, especially regarding treatment de-intensification and organ-preservation. The potential predictive value needs further validation in appropriate control groups. Further research on advanced imaging approaches including radiomics or artificial intelligence methods should implement the identified cut-off values as benchmark routine imaging parameters. Frontiers Media S.A. 2022-06-08 /pmc/articles/PMC9213669/ /pubmed/35756665 http://dx.doi.org/10.3389/fonc.2022.870319 Text en Copyright © 2022 Zschaeck, Weingärtner, Lombardo, Marschner, Hajiyianni, Beck, Zips, Li, Lin, Amthauer, Troost, van den Hoff, Budach, Kotzerke, Ferentinos, Karagiannis, Kaul, Gregoire, Holzgreve, Albert, Nikulin, Bachmann, Kopka, Krause, Baumann, Kazmierska, Cegla, Cholewinski, Strouthos, Zöphel, Majchrzak, Landry, Belka, Stromberger and Hofheinz https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Zschaeck, Sebastian
Weingärtner, Julian
Lombardo, Elia
Marschner, Sebastian
Hajiyianni, Marina
Beck, Marcus
Zips, Daniel
Li, Yimin
Lin, Qin
Amthauer, Holger
Troost, Esther G. C.
van den Hoff, Jörg
Budach, Volker
Kotzerke, Jörg
Ferentinos, Konstantinos
Karagiannis, Efstratios
Kaul, David
Gregoire, Vincent
Holzgreve, Adrien
Albert, Nathalie L.
Nikulin, Pavel
Bachmann, Michael
Kopka, Klaus
Krause, Mechthild
Baumann, Michael
Kazmierska, Joanna
Cegla, Paulina
Cholewinski, Witold
Strouthos, Iosif
Zöphel, Klaus
Majchrzak, Ewa
Landry, Guillaume
Belka, Claus
Stromberger, Carmen
Hofheinz, Frank
18F-Fluorodeoxyglucose Positron Emission Tomography of Head and Neck Cancer: Location and HPV Specific Parameters for Potential Treatment Individualization
title 18F-Fluorodeoxyglucose Positron Emission Tomography of Head and Neck Cancer: Location and HPV Specific Parameters for Potential Treatment Individualization
title_full 18F-Fluorodeoxyglucose Positron Emission Tomography of Head and Neck Cancer: Location and HPV Specific Parameters for Potential Treatment Individualization
title_fullStr 18F-Fluorodeoxyglucose Positron Emission Tomography of Head and Neck Cancer: Location and HPV Specific Parameters for Potential Treatment Individualization
title_full_unstemmed 18F-Fluorodeoxyglucose Positron Emission Tomography of Head and Neck Cancer: Location and HPV Specific Parameters for Potential Treatment Individualization
title_short 18F-Fluorodeoxyglucose Positron Emission Tomography of Head and Neck Cancer: Location and HPV Specific Parameters for Potential Treatment Individualization
title_sort 18f-fluorodeoxyglucose positron emission tomography of head and neck cancer: location and hpv specific parameters for potential treatment individualization
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213669/
https://www.ncbi.nlm.nih.gov/pubmed/35756665
http://dx.doi.org/10.3389/fonc.2022.870319
work_keys_str_mv AT zschaecksebastian 18ffluorodeoxyglucosepositronemissiontomographyofheadandneckcancerlocationandhpvspecificparametersforpotentialtreatmentindividualization
AT weingartnerjulian 18ffluorodeoxyglucosepositronemissiontomographyofheadandneckcancerlocationandhpvspecificparametersforpotentialtreatmentindividualization
AT lombardoelia 18ffluorodeoxyglucosepositronemissiontomographyofheadandneckcancerlocationandhpvspecificparametersforpotentialtreatmentindividualization
AT marschnersebastian 18ffluorodeoxyglucosepositronemissiontomographyofheadandneckcancerlocationandhpvspecificparametersforpotentialtreatmentindividualization
AT hajiyiannimarina 18ffluorodeoxyglucosepositronemissiontomographyofheadandneckcancerlocationandhpvspecificparametersforpotentialtreatmentindividualization
AT beckmarcus 18ffluorodeoxyglucosepositronemissiontomographyofheadandneckcancerlocationandhpvspecificparametersforpotentialtreatmentindividualization
AT zipsdaniel 18ffluorodeoxyglucosepositronemissiontomographyofheadandneckcancerlocationandhpvspecificparametersforpotentialtreatmentindividualization
AT liyimin 18ffluorodeoxyglucosepositronemissiontomographyofheadandneckcancerlocationandhpvspecificparametersforpotentialtreatmentindividualization
AT linqin 18ffluorodeoxyglucosepositronemissiontomographyofheadandneckcancerlocationandhpvspecificparametersforpotentialtreatmentindividualization
AT amthauerholger 18ffluorodeoxyglucosepositronemissiontomographyofheadandneckcancerlocationandhpvspecificparametersforpotentialtreatmentindividualization
AT troostesthergc 18ffluorodeoxyglucosepositronemissiontomographyofheadandneckcancerlocationandhpvspecificparametersforpotentialtreatmentindividualization
AT vandenhoffjorg 18ffluorodeoxyglucosepositronemissiontomographyofheadandneckcancerlocationandhpvspecificparametersforpotentialtreatmentindividualization
AT budachvolker 18ffluorodeoxyglucosepositronemissiontomographyofheadandneckcancerlocationandhpvspecificparametersforpotentialtreatmentindividualization
AT kotzerkejorg 18ffluorodeoxyglucosepositronemissiontomographyofheadandneckcancerlocationandhpvspecificparametersforpotentialtreatmentindividualization
AT ferentinoskonstantinos 18ffluorodeoxyglucosepositronemissiontomographyofheadandneckcancerlocationandhpvspecificparametersforpotentialtreatmentindividualization
AT karagiannisefstratios 18ffluorodeoxyglucosepositronemissiontomographyofheadandneckcancerlocationandhpvspecificparametersforpotentialtreatmentindividualization
AT kauldavid 18ffluorodeoxyglucosepositronemissiontomographyofheadandneckcancerlocationandhpvspecificparametersforpotentialtreatmentindividualization
AT gregoirevincent 18ffluorodeoxyglucosepositronemissiontomographyofheadandneckcancerlocationandhpvspecificparametersforpotentialtreatmentindividualization
AT holzgreveadrien 18ffluorodeoxyglucosepositronemissiontomographyofheadandneckcancerlocationandhpvspecificparametersforpotentialtreatmentindividualization
AT albertnathaliel 18ffluorodeoxyglucosepositronemissiontomographyofheadandneckcancerlocationandhpvspecificparametersforpotentialtreatmentindividualization
AT nikulinpavel 18ffluorodeoxyglucosepositronemissiontomographyofheadandneckcancerlocationandhpvspecificparametersforpotentialtreatmentindividualization
AT bachmannmichael 18ffluorodeoxyglucosepositronemissiontomographyofheadandneckcancerlocationandhpvspecificparametersforpotentialtreatmentindividualization
AT kopkaklaus 18ffluorodeoxyglucosepositronemissiontomographyofheadandneckcancerlocationandhpvspecificparametersforpotentialtreatmentindividualization
AT krausemechthild 18ffluorodeoxyglucosepositronemissiontomographyofheadandneckcancerlocationandhpvspecificparametersforpotentialtreatmentindividualization
AT baumannmichael 18ffluorodeoxyglucosepositronemissiontomographyofheadandneckcancerlocationandhpvspecificparametersforpotentialtreatmentindividualization
AT kazmierskajoanna 18ffluorodeoxyglucosepositronemissiontomographyofheadandneckcancerlocationandhpvspecificparametersforpotentialtreatmentindividualization
AT ceglapaulina 18ffluorodeoxyglucosepositronemissiontomographyofheadandneckcancerlocationandhpvspecificparametersforpotentialtreatmentindividualization
AT cholewinskiwitold 18ffluorodeoxyglucosepositronemissiontomographyofheadandneckcancerlocationandhpvspecificparametersforpotentialtreatmentindividualization
AT strouthosiosif 18ffluorodeoxyglucosepositronemissiontomographyofheadandneckcancerlocationandhpvspecificparametersforpotentialtreatmentindividualization
AT zophelklaus 18ffluorodeoxyglucosepositronemissiontomographyofheadandneckcancerlocationandhpvspecificparametersforpotentialtreatmentindividualization
AT majchrzakewa 18ffluorodeoxyglucosepositronemissiontomographyofheadandneckcancerlocationandhpvspecificparametersforpotentialtreatmentindividualization
AT landryguillaume 18ffluorodeoxyglucosepositronemissiontomographyofheadandneckcancerlocationandhpvspecificparametersforpotentialtreatmentindividualization
AT belkaclaus 18ffluorodeoxyglucosepositronemissiontomographyofheadandneckcancerlocationandhpvspecificparametersforpotentialtreatmentindividualization
AT strombergercarmen 18ffluorodeoxyglucosepositronemissiontomographyofheadandneckcancerlocationandhpvspecificparametersforpotentialtreatmentindividualization
AT hofheinzfrank 18ffluorodeoxyglucosepositronemissiontomographyofheadandneckcancerlocationandhpvspecificparametersforpotentialtreatmentindividualization